Alternatives to Fibionic

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Revolutionizing genomic analysis with innovative sequencing technology.

Pioneering vision restoration therapies for severe retinal degenerations.

Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.

DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing soft, stretchable brain-computer interface platforms.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.